Profile
DXR ISRG BDXA BDX RMD ALC
Company Name Daxor Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $57.86M $167.60B $55.91B $54.60B $40.88B $39.47B
Employees 0.04K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Michael Richard Feldschuh Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
DXR ISRG BDXA BDX RMD ALC
Quant Rating Score 2 3 5 3 4 3
Quant Rating Sell Neutral Strong Buy Neutral Buy Neutral
Trading
DXR ISRG BDXA BDX RMD ALC
Last Close $11.66 $449.68 $59.24 $186.84 $270.14 $78.29
High 52 $11.66 $610.45 $59.24 $249.08 $293.73 $100.07
Low 52 $7.05 $441.23 $59.24 $165.15 $204.58 $77.87
Price vs. 52 Week High 0 % -26.34 % 0 % -24.99 % -8.03 % -21.76 %
Price vs. 52 Week Low 65.39 % 1.92 % 0 % 13.13 % 32.05 % 0.54 %
Total Return
DXR ISRG BDXA BDX RMD ALC
1 Month Return 9.9 % -5.73 % 0 % -4.18 % -5.11 % -9.79 %
3 Month Return 33.26 % -12.2 % 0 % 8.5 % 8.34 % -9.18 %
6 Month Return 42.51 % -7.18 % 0 % -17.32 % 20.51 % -11.99 %
9 Month Return 42.89 % -16.66 % 0 % -17.17 % 13.26 % -6.99 %
YTD Return 51.63 % -13.85 % 0 % -17.64 % 18.12 % -7.77 %
1 Year Return 29.03 % -8.2 % 0 % -20.22 % 8.52 % -20.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DXR ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.13 % 2.18 % 0.78 % 0.42 %
Dividend Paid and Capex Coverage Ration (TTM) -465343.67 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.07 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 22.19 % 15.71 %
Growth
DXR ISRG BDXA BDX RMD ALC
Asset Growth 5.06 % 8.54 % 2.48 %
Gross Profit Growth 1203.92 % 11.69 % 5.05 %
Revenue Growth 1203.92 % 4.16 % 4.82 %
Revenue 3 Year -69.49 % 5.3 % 18.48 %
Revenue 5 Year 1702.1 % 8.72 % 30.35 %
Revenue 10 Year 140.78 % 59.37 % 50.3 %
EBIT Growth 88.46 % 19.82 % 41.82 %
Net Income Growth 91.11 % 14.89 % 4.52 %
Net Income 3 Yeari Growth Per Share -90.58 % -18.63 % 168.34 %
Net Income 5 Yeari Growth Per Share 193.54 % 28.82 % 253.24 %
Net Income 10 Yeari Growth Per Share 142.6 % -4.02 % 239.64 %
Operating Income Growth 402.89 % 13.55 % 36 %
Operating Cash Flow Growth (CFG) 100.7 % 27.07 % 49.64 %
Operating 3 Year CFG 100.78 % -18.4 % 53.05 %
Operating 5 Year CFG -99.29 % 6.25 % 122.93 %
Operating 10 Year CFG 106.74 % 45.28 % 55.79 %
EPS Growth 81.52 % 18.31 % 4.04 %
EPS Diluted Growth 81.52 % 18.62 % 4.59 %
Book Value Per Share 0.65 % -0.85 % 4.21 %
Share Holder 3 Year Equity Growth Per Share 41.05 % 9.16 % 10.93 %
Share Holder 5 Year Equity Growth Per Share 142.4 % 14.4 % 10.26 %
Share Holder 10 Year Equity Growth Per Share 12.96 % 241.78 % -9.87 %
Dividend Per Share Growth - -2.44 % 11.75 %
Dividend 3 Year Growth Per Share - 4.79 % 138.09 %
Dividend 5 Year Growth Per Share - 4.14 % -
Dividend 10 Year Growth Per Share -100 % 74.3 % -
Debt Growth -100 % 31.74 % 0.02 %
Free Cash Flow Growth 100.7 % 45.25 % 162.01 %
Updated On 31 Dec 2024 30 Sep 2024 31 Dec 2024
Profitability
DXR ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 90.27 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM 1.46 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM 1.57 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM 5.21 % 14.26 % 5.78 % 5.78 % 23.58 % 4.98 %
Net Income Per EBT TTM -49 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM -57.37 % 113.2 % 70.86 % 70.86 % 99.42 % 86.96 %
EBIT Per Revenue TTM 248.71 % 28.8 % 12.63 % 12.63 % 32.79 % 14.38 %
Cash Flow To Debt Ratio TTM - - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 79.26 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM - 11.43 - 1.85 7.52 5.03
Inventory Turnover TTM - 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM - 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 2.09 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM -0.28 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -0.28 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM - 1485.77 % 262.85 % 262.85 % 834.65 % 284.33 %
Operating Cash Flow Sales Ratio TTM -182 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM - - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -41.45 84.04 21.5 21.41 24.64 24.7
Price To Operating Cash Flows Ratio TTM -41.21 59.31 16.93 16.86 23.35 19.17
Price Cash Flow Ratio TTM -41.21 59.31 16.93 16.86 23.35 19.17
Income Statement (TTM)
DXR ISRG BDXA BDX RMD ALC
Revenue $0B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $0B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 100% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $0B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $0B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted 0.11 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
DXR ISRG BDXA BDX RMD ALC
Long Term Debt $0B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $0B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $0.04B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0.04B $7.05B $0.45B $0.45B $0.1B $0.91B
Total Debt $0B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $0.04B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
DXR ISRG BDXA BDX RMD ALC
Net Income $0B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $0B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $0B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.29
ANGO AngioDynamics, Inc. 10.65
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 135.23
ATRC AtriCure, Inc. 35.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 29.66
BAX Baxter International Inc. 23.99
BDX Becton, Dickinson and Company 186.84
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.19
BLFS BioLife Solutions, Inc. 25.51
COO The Cooper Companies, Inc. 66.68
EKSO Ekso Bionics Holdings, Inc. 3.83
FEMY Femasys Inc. 0.3921
GCTK GlucoTrack, Inc. 10.59
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 324.31
VTSAX Vanguard Total Stock Market Index Fund 0 157.86
VITSX Vanguard Total Stock Market Index Fund 0 157.89
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 488
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 296.18
Unlock